Association of the British Pharmaceutical Industry (1999) ABPI Compendium of Data Sheets and Summaries of Product Characteristics 1999–2000.
London: Datapharm Publications Limited.
British Association for Psychopharmacology (1997) BAP consensus statement. Child and learning disability psychopharmacology. Journal of Psychopharmacology, 11, 291–294.
British Medical Association & Royal Pharmaceutical Society of Great Britain (1999) British National Formulary.
London: Wallingford: BMJ Books. Pharmaceutical Press.
Conroy, S., Choonare, I., Impicciatore, P., et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. British Medical Journal, 320, 79–82.
Healy, D. & Nutt, D. (1998) Prescriptions, licences and evidence. Psychiatric Bulletin, 22, 680–684.
Lowe-Ponsford, F. L. (1999) Anticonvulsants in the treatment of bipolar disorder. In Practical Issues in Mood and Anxiety Disorders. No. 8. The Netherlands: SmithKline Beecham.
Milton, J., Lawton, J., Smith, M., et al (1998) Hidden high-dose antipsychotic prescribing: effects of p.r.n. doses. Psychiatric Bulletin, 22, 675–677.
Thompson, C. (for the Royal College of Psychiatrists' Panel) (1994) The use of high-dose antipsychotic medication (Consensus statement). British Journal of Psychiatry, 164, 448–458.
Vitello, B. & Jensen, P. S. (1997) Medication development and testing in children and adolescents. Archives of General Psychiatry, 54, 871–876.
Bolam v. Friern Hospital Management Committee  .
Bolitho v. City and Hackney Health Authority  .